NCT05029869View on ClinicalTrials.gov

Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description

Active, not recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

October 4, 2021

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions

Gastric CancerctDNA

Interventions

DIAGNOSTIC_TEST

ctDNA

The blood samples for ctDNA and other tumor markers will be first collected within 14 days before surgery, and then be tested after gastrectomy in scheduled interval

Trial Locations (1)

700000

University Medical Center Ho Chi Minh City, Ho Chi Minh City

All Listed Sponsors

lead

University Medical Center Ho Chi Minh City (UMC)

OTHER